In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of CryoPort Inc (NASDAQ: CYRX) was $5.56 for the day, up 0.72% from the previous closing price of $5.52. In other words, the price has increased by $0.72 from its previous closing price. On the day, 0.6 million shares were traded. CYRX stock price reached its highest trading level at $5.7468 during the session, while it also had its lowest trading level at $5.445.
Ratios:
Our analysis of CYRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.94 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.57.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.
Jefferies Downgraded its Buy to Hold on August 07, 2024, whereas the target price for the stock was revised from $20 to $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 ’25 when Sawicki Mark W sold 1,349 shares for $6.94 per share. The transaction valued at 9,364 led to the insider holds 84,087 shares of the business.
STEFANOVICH ROBERT sold 1,070 shares of CYRX for $7,428 on Mar 24 ’25. The Chief Financial Officer now owns 190,349 shares after completing the transaction at $6.94 per share. On Mar 24 ’25, another insider, SHELTON JERRELL, who serves as the President, CEO of the company, sold 2,980 shares for $6.94 each. As a result, the insider received 20,686 and left with 762,419 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 277501824 and an Enterprise Value of 300730784. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.22 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at 1.317 whereas that against EBITDA is -8.504.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.85, which has changed by -0.6574245 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $17.41, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is -7.77%, while the 200-Day Moving Average is calculated to be -24.88%.
Shares Statistics:
CYRX traded an average of 460.22K shares per day over the past three months and 507230 shares per day over the past ten days. A total of 49.91M shares are outstanding, with a floating share count of 48.07M. Insiders hold about 3.68% of the company’s shares, while institutions hold 95.09% stake in the company. Shares short for CYRX as of 1743379200 were 2443367 with a Short Ratio of 5.31, compared to 1740700800 on 2046167. Therefore, it implies a Short% of Shares Outstanding of 2443367 and a Short% of Float of 5.88.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
